Reciprocally, activated ECs can then secrete additional growth factors that promote glioma stem cell maintenance and tumor development, including transforming growth factor-beta (TGF-β), fibroblast growth factor (FGF), and EGF. The gene discussed is TGFB1; the disease is neoplasm.